Decisions regarding resumption of anticoagulation are difficult in patients who present with a warfarin-associated intracranial hemorrhage and also have atrial fibrillation or a prosthetic heart valve. Current guidelines suggest waiting 1–2 weeks on average, but new research suggests that the optimal time to restart anticoagulation could be much later.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rowan, S. B., Bailey, D. N., Bublitz, C. E. & Anderson, R. J. Trends in anticoagulation for atrial fibrillation in the US: an analysis of the National Ambulatory Medical Center Survey database. J. Am. Coll. Cardiol. 49, 1561–1565 (2007).
EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342, 1255–1262 (1993).
Salem, D. N., O'Gara, P. T., Madias, C. & Pauker, S. G. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133, 593S–629S (2008).
Hart, R. G., Tonarelli, S. B. & Pearce, L. A. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 36, 1588–1593 (2005).
Majeed, A., Kim, Y.-K., Roberts, R. S., Homstrom, M. & Schulman, S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke 41, 2860–2866 (2010).
Broderick, J. et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality Care and Outcomes in Research Interdisciplinary Working Group. Circulation 116, e391–e413 (2007).
Aguilar, M. I. et al. Treatment of warfarin-associated intracerebral hemorrhage: Literature review and expert opinion. Mayo Clin. Proc. 82, 82–92 (2007).
Bertram, M., Bonsanto, M., Hacke, W. & Schwab, S. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J. Neurol. 247, 209–214 (2000).
PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischemic attack. Lancet 358, 1033–1041 (2001).
Rosand, J., Hylek, E. M., O'Donnel, K. C. & Greenberg, S. M. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathological study. Neurology 55, 947–951 (2000).
Acknowledgements
E. B. Marsh is the recipient of an NIH/National Institute of Neurological Disorders and Stroke R25 training grant on an associated topic, which will assist in funding some of her salary support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Marsh, E., Gottesman, R. Restarting anticoagulation after intracranial hemorrhage. Nat Rev Neurol 7, 130–132 (2011). https://doi.org/10.1038/nrneurol.2011.6
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2011.6